skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Due in no small part to the advice received from 5i, I find myself in the enviable position of having capital to deploy freely. For a TFSA, what would be 5 of your top growth picks today?
Thanks for all you do.
Read Answer Asked by Andrew on February 05, 2021
Q: Le Chateau has closed all their physical stores and there online sales have been growing. Wells Fargo is in the drivers seat and looks like it has been able to re-coup most if not all the loan. What do you think Wells Fargo will do with the company? It appears, Insiders own most of the shares.
Read Answer Asked by Robert on February 05, 2021
Q: Almost 80% of the holdings in MCHI are HK-listed companies. Given China’s overly aggressive moves in HK, would you consider Chinese companies listed in HK to be at a higher risk than they have been in the past? I am comfortable adding to the Chinese tech ETF CQQQ.us, but I wonder about the companies held in MCHI.

I would love to know your opinion on the above with a bit of detail.

Why China is grouped with ÉM is unfathomable to me. In your own way of thinking about allocation, do you mentally remove China from the ÉM basket? It seems long overdue for both the political and investment worlds to treat her as developed.
Read Answer Asked by Adam on February 05, 2021
Q: I have MDT whose shares have been in a muted trading range for more than a year. Understandable reasons— e.g. postponement of elective surgeries &c.). However I then checked the 10-year performance of the medical equipment ETF , IHI.us, with that of MDT. To my surprise, MDT has not outperformed IHI in ANY part of an entire decade (I used charts at Scotia’s FlightDesk for this).

Several analyst shops seems to favor MDT, as do you. Has something changed in recent months to boost the prospects of MDT?

If this is a good time to add to one’s holding in MDT, please comment on whether the following metrics from GuruFocus are correct:
TTM P/E : 42.98 and ROE less than 7%. Further, I see y-y EBITDA Growth Rate % of [gasp] minus -30.10 and PEG of 11.45.
Can this be correct for a well-regarded company ? Kindly give your data for forward P/E , PEG , and please confirm whether cash flow from operations is adequate for operations and to meet debt obligations.


Read Answer Asked by Adam on February 05, 2021
Q: Hi Team,
Previously (I believe it was sometime in 2020) in your answer to questions on US estate tax payable by Canadians, it was pointed out that the threshold for US estate tax is US$11.2M (to be reduced to US$4 or 5M in 2023?), meaning no US estate tax is payable if value of world-wide assets is under US$11.2M. Amounts in excess of this threshold is subject to US estate tax with some credits allowed as per the Canada-US tax treaty.
Please confirm if your previous statement regarding US estate tax is still applicable.
Cheers,
Read Answer Asked by Harry on February 05, 2021
Q: Hi Peter, Ryan, and Team,
This is a two-part question, so please feel free to deduct enough credits.
(1) In Portfolio Analytics, is it appropriate to enter zero for the cost basis? After all, we didn't pay anything for these shares. (Thank you 5i)
(2) In our combined accounts, prior to the spin-out, we were already overweight in Technology, holding ABST, CSU, ENGH, XIT, and KXS. In order to balance our accounts, what, if anything, would you recommend we do? It would be costly to reduce all the holdings which I'm reluctant to do.
Thanks in advance for your valued advice and opinion.
Read Answer Asked by Jerry on February 05, 2021
Q: I missed your talk on the money show. Would you be able to provide a link please?
Read Answer Asked by Steven on February 05, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!